You have 9 free searches left this month | for more free features.

City

Augusta (1)

Condition

Alpha 1-Antitrypsin Deficiency (2)

Acute Graft-Versus-Host Reaction Following Bone Marrow Transplant (1)

Acute-graft-versus-host Disease (1)

Alpha-1 Protease Inhibitor Deficiency (1)

Alpha-1 Proteinase Inhibitor (1)

Graft Versus Host Disease (1)

Graft Vs Host Disease (1)

Graft-versus-host-disease (1)

Steroid Refractory Acute Graft Versus Host Disease (1)

Overall Status

No longer available (1)

Terminated (1)

Withdrawn (1)

Sign in for free

Phase

phase 2 (1)

phase 2/phase 3 (1)

Sponsor

Baxalta now part of Shire (1)

Impatients N.V. trading as myTomorrows (1)

Octapharma (1)

Collaborator

Kamada, Ltd. (2)

Intervention

glassia (3)

albumin (1)

methylprednisolone or equivalent steroid (1)

octaalpha1 (1)

Study Documents

Intervention Type

drug (3)

biological (1)

Funder Type

Industry (3)

Study Type

Interventional (2)

Expanded Access (1)

glassia

Showing 1 - 3 of 3

Trials per page:

STUDY

CONDITIONS

INTERVENTIONS

LOCATIONS

LAST UPDATED

GVHD Trial in Augusta (GLASSIA, methylprednisolone or equivalent steroid, Albumin)

Terminated

Has Results

Graft Versus Host Disease

GLASSIA
+2 more

Augusta, Georgia

Georgia Cancer Center

Dec 22, 2020

Acute-graft-versus-host Disease, Steroid Refractory Acute GVHD, Graft-versus-host-disease Trial (Glassia)

No longer available

Acute-graft-versus-host Disease
+7 more

Glassia

(no location specified)

Sep 30, 2020

Alpha 1-Antitrypsin Deficiency Trial (OctaAlpha1, Glassia)

Withdrawn

Alpha 1-Antitrypsin Deficiency

OctaAlpha1
Glassia

(no location specified)

Apr 6, 2018